推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Journal for ImmunoTherapy of Cancer

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 J IMMUNOTHER CA最新评论:请问你找到了?麻烦指导一下 (2024-03-20)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Journal for ImmunoTherapy of Cancer期刊基本信息Hello,您是该期刊的第68767位访客

基本信息 登录收藏
期刊名字Journal for ImmunoTherapy of CancerJournal for ImmunoTherapy of Cancer

J IMMUNOTHER CANCER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.5
51人评分
我要评分

声誉
9.5

影响力
8.0

速度
7.0

期刊ISSN2051-1426
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
10.9 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:8.532
2022-2023自引率4.60%点击查看自引率趋势图
五年影响因子12.6
h-index 36
CiteScore
CiteScoreSJRSNIPCiteScore排名
16.803.4031.851
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q110 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q112 / 171
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Oncology
Q126 / 366
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Cancer Research
Q120 / 214
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Immunology and Allergy
Q120 / 211
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Immunology
Q124 / 217

期刊简介
Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.
期刊官方网站https://www.springer.com/journal/40425
期刊投稿网址https://www.editorialmanager.com/JITC
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Journal for ImmunoTherapy of Cancer的语言要求,还能让Journal for ImmunoTherapy of Cancer编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Journal for ImmunoTherapy of Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2600; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:tumour immunology、cancer immunotherapy、immunotherapy biomarkers
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR
出版商BioMed Central
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Molecular Medicine
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份2013
年文章数 509点击查看年文章数趋势图
Gold OA文章占比99.29%
研究类文章占比:
文章 ÷(文章 + 综述)
92.14%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:IMMUNOLOGY
类别:SCIE
Q118/161
学科:ONCOLOGY
类别:SCIE
Q129/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
IMMUNOLOGY
免疫学
3区3区1区
ONCOLOGY
肿瘤学
2区2区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区1区
IMMUNOLOGY
免疫学
4区3区2区
ONCOLOGY
肿瘤学
1区4区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
IMMUNOLOGY
免疫学
3区2区2区
ONCOLOGY
肿瘤学
3区1区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-1426%5BISSN%5D
平均审稿速度网友分享经验:
18 Weeks
平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Journal for ImmunoTherapy of Cancer顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Journal for ImmunoTherapy of Cancer期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Journal for ImmunoTherapy of Cancer中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Journal for ImmunoTherapy of Cancer上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Biomarker Research012.10
    Cell Chemical Biology16614.90
    Molecular Oncology6311.80
    VIROLOGICA SINICA207.70
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE010.00
    Biotechnology Journal7010.30
    Molecular Biomedicine03.30
    Frontiers in Genetics615.20
    Pharmacogenomics & Personalized Medicine03.10
    Advances in Biological Regulation010.40
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599853
    BIOMATERIALS512715
    BIOMEDICINE & PHARMACOTHERAPY461872
    Journal of Materials Chemistry B458414
    Frontiers in Pharmacology448222
    Frontiers in Immunology419219
    JOURNAL OF ETHNOPHARMACOLOGY403604
    COLLOIDS AND SURFACES B-BIOINTERFACES403093
    Frontiers in Oncology382532
    Acta Biomaterialia374633
  •  

    Journal for ImmunoTherapy of Cancer Journal for ImmunoTherapy of Cancer
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation

    Author: Zhang, Biying; Li, Jiao; Hua, Qingling; Wang, Haihong; Xu, Guojie; Chen, Jiayuan; Zhu, Ying; Li, Ruiqi; Liang, Qing; Wang, Lanqing; Jin, Min; Tang, Jing; Lin, Zhenyu; Zhao, Lei; Zhang, Dejun; Yu, Dandan; Ren, Jinghua; Zhang, Tao
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005592
        PubMed      DOI
    2.Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy

    Author: Tang, Rui; He, Hongye; Lin, Xiaohong; Wu, Nianhong; Wan, Li; Chen, Qiaoqi; Hu, Yaqin; Cheng, Chen; Cao, Yuting; Guo, Xun; Zhou, Ying; Xiong, Xialin; Zheng, Min; Wang, Qi; Li, Faqi; Zhou, Yang; Li, Pan
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-006226
        PubMed      DOI
    3.Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy

    Author: Shi, Lin; Lu, Jinying; Zhong, Da; Song, Meijuan; Liu, Jian; You, Wenhua; Li, Wen-Hui; Lin, Lin; Shi, Dongyan; Chen, Yun
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005902
        PubMed      DOI
    4.STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

    Author: Ding, Liya; Wang, Qiwei; Martincuks, Antons; Kearns, Michael J.; Jiang, Tao; Lin, Ziying; Cheng, Xin; Qian, Changli; Xie, Shaozhen; Kim, Hye-Jung; Launonen, Inga-Maria; Faerkkilae, Anniina; Roberts, Thomas M.; Freeman, Gordon J.; Liu, Joyce F.; Konstantinopoulos, Panagiotis A.; Matulonis, Ursula; Yu, Hua; Zhao, Jean J.
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005627
        PubMed      DOI
    5.Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy

    Author: Dai, Jie; Bai, Xue; Gao, Xuan; Tang, Lirui; Chen, Yu; Sun, Linzi; Wei, Xiaoting; Li, Caili; Qi, Zhonghui; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Xu, Zelong; Lian, Bin; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Wang, Xuan; Xia, Xuefeng; Guo, Jun; Mao, Lili; Si, Lu
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005937
        PubMed      DOI
    6.New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

    Author: Bamias, Aristotelis; Merseburger, Axel; Loriot, Yohann; James, Nicholas; Choy, Ernest; Castellano, Daniel; Lopez-Rios, F.; Calabro, Fabio; Kramer, Mario; de Velasco, Guillermo; Zakopoulou, Roubini; Tzannis, Kimon; Sternberg, Cora N.
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2022-005977
        PubMed      DOI
    7.Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers

    Author: Ba, Hongping; Dai, Zigang; Zhang, Zunyue; Zhang, Peng; Yin, Bingjiao; Wang, Jing; Li, Zhuoya; Zhou, Xiaoxi
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.1136/jitc-2021-003837
        PubMed      DOI
    8.Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases

    Author: Zhang, Chong; Wang, Xiang-Yu; Zuo, Jie-Liang; Wang, Xue-Fu; Feng, Xiao-Wen; Zhang, Bo; Li, Yi-Tong; Yi, Chen-He; Zhang, Peng; Ma, Xiao-Chen; Chen, Zhen-Mei; Ma, Yue; Han, Jia-Hao; Tao, Bao-Rui; Zhang, Rui; Wang, Tian-Qi; Tong, Li; Gu, Wang; Wang, Si-Yu; Zheng, Xiao-Fei; Yuan, Wen-Kang; Kan, Zi-Jie; Fan, Jie; Hu, Xiang-Yang; Li, Jun; Zhang, Chao; Chen, Jin-Hong
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1136/jitc-2022-006425
        PubMed      DOI
    9.T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma

    Author: Wang, Xiaobin; Zhang, Qiaoyun; Zhou, Jingwen; Xiao, Zecong; Liu, Jianxin; Deng, Shaohui; Hong, Xiaoyang; Huang, Wensou; Cai, Mingyue; Guo, Yongjian; Huang, Jingjun; Wang, Yong; Lin, Liteng; Zhu, Kangshun
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1136/jitc-2022-006493
        PubMed      DOI
    10.Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability

    Author: Tang, Jianghui; Sheng, Jianpeng; Zhang, Qi; Ji, Yongtao; Wang, Xun; Zhang, Junlei; Wu, Jiangchao; Song, Jinyuan; Bai, Xueli; Liang, Tingbo
    Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023; Vol. 11, Issue 2, pp. -. DOI: 10.1136/jitc-2022-006119
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共231条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451